Explore / Clinical trial
Clinical trial

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

University Hospital, Basel, SwitzerlandCompletedPhase 1Started Jun 1, 200116 enrolledSwitzerlandNCT00895804

Abstract

MDMA (3,4-Methylenedioxymethamphetamine, "Ecstasy") produces tachycardia, hypertension, hyperthermia, and other acute adverse effects. Ecstasy use has also been associated with rare cardio- and cerebrovascular complications. The role of beta-blockers in the treatment of cardiovascular and adverse effects of MDMA is unknown.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMAAddiction

Keywords

beta adrenergicEcstasyMood DisorderSubstance-Related DisordersAmphetamine-Related Disorders

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.